Physician profile
Ailian Chen
NPI 1831298801
$782.94
in general payments reported to CMS, 2019-2025
9 companies · $90.49 in 2025
The $90.49 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $54.28 · 2022: $176 · 2023: $162 · 2024: $77.13 · 2025: $90.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $329.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $205.01 | 2022-2025 | Freestyle Libre 3 |
| Horizon Therapeutics Plc | $180.44 | 2022-2023 | Tepezza |
| Novo Nordisk INC | $119.64 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.29 | 2019 | |
| Mis Implants Technologies, INC. | $75.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $43.26 | 2019 | |
| Dentsply Sirona INC | $31.80 | 2020 | |
| Ge Healthcare | $22.48 | 2020 | |
| Merck Sharp & Dohme LLC | $14.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ailian Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.